Rumors are growing in Washington that a second Trump administration may aggressively pursue federal cannabis rescheduling. If it happens, it would reshape banking, insurance, taxes, and interstate commerce — transforming the entire cannabis industry.

A new federal amendment will ban hemp-derived THC products exceeding 0.4 mg THC per container, effectively eliminating the intoxicating hemp category. The rule will reshape the $28 billion hemp-THC industry and force businesses to prepare for major operational changes.

Congress’s latest budget deal would restrict hemp-derived THC products while removing provisions allowing VA doctors to recommend medical marijuana. The move tightens federal hemp oversight and highlights how cannabis reform momentum is slowing at the national level.

Republican support for federal cannabis legalization has dropped from 55% to 40%, according to a new Gallup poll. The decline highlights growing political polarization around cannabis — and potential challenges for federal reform heading into 2026.